发明名称 Polypeptide variants with raised heparin-binding capacity
摘要 The invention pertains to polypeptide variants with increased heparin-binding ability. Increased heparin-binding ability is achieved by addition, insertion, and/or substitution of an amino acid sequence X<SUB>1</SUB>X<SUB>2</SUB>X<SUB>3</SUB>X<SUB>4</SUB>X<SUB>5</SUB>X<SUB>6 </SUB>(SEQ ID NO. 1 or NO.2). Polypeptide variants according to the invention are particularly suited for stimulation of chondrogenesis, osteogenesis, and wound healing. The invention also pertains to amino acid molecules that encode said polypeptide variants, host cells containing said nucleic acid molecules, and processes for producing the polypeptide variants.
申请公布号 AU2110600(A) 申请公布日期 2000.08.29
申请号 AU20000021106 申请日期 2000.01.27
申请人 OSTEOGENETICS GMBH 发明人 PROF. DR. WALTER SEBALD
分类号 C12N15/09;A61K31/727;A61K38/00;A61K38/18;A61K47/04;A61K47/30;A61K47/36;A61K47/42;A61K47/48;A61P17/02;A61P19/00;A61P19/08;A61P29/00;A61P35/00;C07K7/08;C07K14/47;C07K14/51;C12N1/15;C12N1/19;C12N5/10;C12N15/12;C12N15/62;C12P21/02 主分类号 C12N15/09
代理机构 代理人
主权项
地址